Tapewire

NYSE · USD

PG

PROCTER & GAMBLE Co

Export transactions ↓
Tapewire entity
2814
SEC CIK
0000080424
Parsed reports
3,815

Last 12 months

Inside the activity.

0 purchase rows · 31 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202601
Feb 2026011
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026015
Sep 202600
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 21, 2020 Filed Apr 22, 2020 15:06 UTC
Sheppard Valarie LController, Treas. & Exec. VP
SaleCommon Stock 25,600 $119.50 $3,059,200.00
Disclosure

SEC source: 0001127602-20-014254 · form4.xml · nonDerivative · entry 2

Sheppard Valarie L · CIK 0001334175 · Controller, Treas. & Exec. VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,998.487

Read SEC document
April 21, 2020 Filed Apr 22, 2020 15:06 UTC
Sheppard Valarie LController, Treas. & Exec. VP
Exercise / conversionCommon Stock 25,600 $63.05 $1,614,080.00
Disclosure

SEC source: 0001127602-20-014254 · form4.xml · nonDerivative · entry 1

Sheppard Valarie L · CIK 0001334175 · Controller, Treas. & Exec. VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,598.487

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 21, 2020 Filed Apr 22, 2020 17:42 UTC
Keith R. AlexandraCEO - Beauty
SaleCommon Stock 7,360 $120.00 $883,200.00
Disclosure

SEC source: 0001127602-20-014269 · form4.xml · nonDerivative · entry 1

Keith R. Alexandra · CIK 0001710268 · CEO - Beauty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,746.032

Read SEC document
April 21, 2020 Filed Apr 22, 2020 22:28 UTC
PELTZ NELSONDirector
SaleCommon Stock 287,202 $119.65 $34,362,570.49
Disclosure

SEC source: 0001209191-20-025378 · doc4.xml · nonDerivative · entry 4

PELTZ NELSON · CIK 0000928265 · Director

TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Please see explanation below

Disclosed balance after: 28,930,465

F1 · kind: Primarily represents sales of shares made in connection with the expiration this year of a multi-year lockup period of a Trian Entity (as defined below).

F7 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $119.50 to $120.00. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., Trian Partners Co-Investment Opportunities Fund, Ltd. and Trian SPV (Sub) XII, L.P (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them.

F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer.

Read SEC document
April 20, 2020 Filed Apr 21, 2020 18:30 UTC
Majoras Deborah PChief Legal Officer & Secy
SaleCommon Stock 12,589 $122.68 $1,544,418.52
Disclosure

SEC source: 0001127602-20-014200 · form4.xml · nonDerivative · entry 1

Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,948.151

F1 · price: Weighted average price of the shares sold. The price range was $122.51 to $122.94. Full information regarding the number of shares sold at each separate price available upon request.

Read SEC document
April 20, 2020 Filed Apr 22, 2020 22:28 UTC
PELTZ NELSONDirector
SaleCommon Stock 80,305 $122.88 $9,867,605.36
Disclosure

SEC source: 0001209191-20-025378 · doc4.xml · nonDerivative · entry 3

PELTZ NELSON · CIK 0000928265 · Director

TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Please see explanation below

Disclosed balance after: 29,217,667

F1 · kind: Primarily represents sales of shares made in connection with the expiration this year of a multi-year lockup period of a Trian Entity (as defined below).

F6 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $122.6300 to $123.1850. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., Trian Partners Co-Investment Opportunities Fund, Ltd. and Trian SPV (Sub) XII, L.P (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them.

F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer.

Read SEC document
April 20, 2020 Filed Apr 22, 2020 22:28 UTC
PELTZ NELSONDirector
SaleCommon Stock 979,988 $122.10 $119,660,650.75
Disclosure

SEC source: 0001209191-20-025378 · doc4.xml · nonDerivative · entry 2

PELTZ NELSON · CIK 0000928265 · Director

TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Please see explanation below

Disclosed balance after: 29,297,972

F1 · kind: Primarily represents sales of shares made in connection with the expiration this year of a multi-year lockup period of a Trian Entity (as defined below).

F5 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $121.6350 to $122.6250. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., Trian Partners Co-Investment Opportunities Fund, Ltd. and Trian SPV (Sub) XII, L.P (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them.

F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer.

Read SEC document
April 20, 2020 Filed Apr 22, 2020 22:28 UTC
PELTZ NELSONDirector
SaleCommon Stock 752,934 $121.39 $91,396,474.75
Disclosure

SEC source: 0001209191-20-025378 · doc4.xml · nonDerivative · entry 1

PELTZ NELSON · CIK 0000928265 · Director

TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Please see explanation below

Disclosed balance after: 30,277,960

F1 · kind: Primarily represents sales of shares made in connection with the expiration this year of a multi-year lockup period of a Trian Entity (as defined below).

F2 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $120.6466 to $121.6300. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., Trian Partners Co-Investment Opportunities Fund, Ltd. and Trian SPV (Sub) XII, L.P (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them.

F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 17:10 UTC GrantCommon Stock 260 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-010378 · form4.xml · nonDerivative · entry 1

LUNDGREN TERRY J · CIK 0001184471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,169.447

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 17:36 UTC GrantCommon Stock 249 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-010387 · form4.xml · nonDerivative · entry 1

Braly Angela F · CIK 0001321458 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,841.3708

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 17:37 UTC GrantCommon Stock 249 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-010388 · form4.xml · nonDerivative · entry 1

JIMENEZ JOSEPH · CIK 0001199095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,905.563

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 17:38 UTC GrantCommon Stock 208 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-010390 · form4.xml · nonDerivative · entry 1

BLAKE FRANCIS S · CIK 0001194702 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,985.209

F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 17:39 UTC GrantCommon Stock 249 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-010392 · form4.xml · nonDerivative · entry 1

McCarthy Christine M · CIK 0001332169 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,923.131

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 17:41 UTC GrantCommon Stock 291 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-010393 · form4.xml · nonDerivative · entry 1

MCNERNEY W JAMES JR · CIK 0001182055 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,026.409

F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
March 10, 2020 Filed Mar 12, 2020 17:42 UTC GrantCommon Stock 312 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-010394 · form4.xml · nonDerivative · entry 1

WOERTZ PATRICIA A · CIK 0001194945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,546.379

F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units.

Read SEC document
February 28, 2020 Filed Feb 28, 2020 19:30 UTC
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
SaleCommon Stock 1,641 $110.44 $181,232.04
Disclosure

SEC source: 0001127602-20-008304 · form4.xml · nonDerivative · entry 2

TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,421.352

F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award.

Read SEC document
February 28, 2020 Filed Feb 28, 2020 19:31 UTC
Keith R. AlexandraCEO - Beauty
SaleCommon Stock 1,041 $110.44 $114,968.04
Disclosure

SEC source: 0001127602-20-008305 · form4.xml · nonDerivative · entry 4

Keith R. Alexandra · CIK 0001710268 · CEO - Beauty

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 8,475.381

F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award.

Read SEC document
February 28, 2020 Filed Feb 28, 2020 19:31 UTC
Keith R. AlexandraCEO - Beauty
SaleCommon Stock 4,311 $110.44 $476,106.84
Disclosure

SEC source: 0001127602-20-008305 · form4.xml · nonDerivative · entry 3

Keith R. Alexandra · CIK 0001710268 · CEO - Beauty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,851.032

F1 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award.

Read SEC document
February 28, 2020 Filed Feb 28, 2020 19:32 UTC
Taylor David SDirector · Chairman, President & CEO
SaleCommon Stock 14,061 $110.44 $1,552,896.84
Disclosure

SEC source: 0001127602-20-008306 · form4.xml · nonDerivative · entry 1

Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,343.6064

F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award.

Read SEC document
February 28, 2020 Filed Feb 28, 2020 19:33 UTC
FergusonMchugh MaryLynnCEO - Family Care & P&G Ventur
SaleCommon Stock 2,275 $110.44 $251,251.00
Disclosure

SEC source: 0001127602-20-008307 · form4.xml · nonDerivative · entry 2

FergusonMchugh MaryLynn · CIK 0001613133 · CEO - Family Care & P&G Ventur

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,714.7592

F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award.

Read SEC document
February 28, 2020 Filed Feb 28, 2020 19:35 UTC
Moeller Jon RVice Chairman, COO and CFO
SaleCommon Stock 387 $110.44 $42,740.28
Disclosure

SEC source: 0001127602-20-008308 · form4.xml · nonDerivative · entry 4

Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 6,699.52

F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award.

Read SEC document
February 28, 2020 Filed Feb 28, 2020 19:35 UTC
Moeller Jon RVice Chairman, COO and CFO
SaleCommon Stock 3,185 $110.44 $351,751.40
Disclosure

SEC source: 0001127602-20-008308 · form4.xml · nonDerivative · entry 3

Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,811.18

F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award.

Read SEC document
February 28, 2020 Filed Feb 28, 2020 19:37 UTC
Majoras Deborah PChief Legal Officer & Secy
SaleCommon Stock 2,213 $110.44 $244,403.72
Disclosure

SEC source: 0001127602-20-008309 · form4.xml · nonDerivative · entry 2

Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,296.151

F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award.

Read SEC document
February 28, 2020 Filed Feb 29, 2020 00:50 UTC
PELTZ NELSONDirector
OtherCommon Stock 113,753 $113.23 $12,880,252.19
Disclosure

SEC source: 0001209191-20-014221 · doc4.xml · nonDerivative · entry 1

PELTZ NELSON · CIK 0000928265 · Director

TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Please see explanation below

Disclosed balance after: 31,030,894

F1 · kind: Represents the completion of a distribution of shares, initiated on February 21, 2020 and reported on the Reporting Persons' Form 4 filed on February 25, 2020, to a limited partner of the parent of a Trian Entity (defined below) in connection with the expiration of a lock-up period.

F2 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Co-Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P., Trian Partners Strategic Fund-C, Ltd., Trian Partners Co-Investment Opportunities Fund, Ltd. and Trian SPV (Sub) XII, L.P (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them.

F3 · ownership.nature: (FN 2, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer.

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:15 UTC
Moeller Jon RVice Chairman, COO and CFO
GrantStock Option (Right to Buy) · Derivative 13,534 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008524 · form4.xml · derivative · entry 6

Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 13,534

Underlying: Common Stock · 13,534 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:15 UTC
Moeller Jon RVice Chairman, COO and CFO
GrantStock Option (Right to Buy) · Derivative 173,268 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008524 · form4.xml · derivative · entry 5

Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,268

Underlying: Common Stock · 173,268 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:15 UTC
Moeller Jon RVice Chairman, COO and CFO
GrantCommon Stock 604 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-008524 · form4.xml · nonDerivative · entry 2

Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 7,303.52

F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan.

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:15 UTC
Moeller Jon RVice Chairman, COO and CFO
GrantCommon Stock 7,728 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-008524 · form4.xml · nonDerivative · entry 1

Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,539.18

F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan.

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:17 UTC
Jejurikar ShaileshCEO - Fabric & Home Care
GrantStock Option (Right to Buy) · Derivative 110,501 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008528 · form4.xml · derivative · entry 5

Jejurikar Shailesh · CIK 0001746310 · CEO - Fabric & Home Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,501

Underlying: Common Stock · 110,501 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:18 UTC
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
GrantStock Option (Right to Buy) · Derivative 81,199 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008531 · form4.xml · derivative · entry 5

TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,199

Underlying: Common Stock · 81,199 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:18 UTC
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
GrantCommon Stock 3,622 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-008531 · form4.xml · nonDerivative · entry 1

TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,043.352

F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan.

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:19 UTC
Keith R. AlexandraCEO - Beauty
GrantStock Option (Right to Buy) · Derivative 6,250 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008534 · form4.xml · derivative · entry 6

Keith R. Alexandra · CIK 0001710268 · CEO - Beauty

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 6,250

Underlying: Common Stock · 6,250 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:19 UTC
Keith R. AlexandraCEO - Beauty
GrantStock Option (Right to Buy) · Derivative 28,038 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008534 · form4.xml · derivative · entry 5

Keith R. Alexandra · CIK 0001710268 · CEO - Beauty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,038

Underlying: Common Stock · 28,038 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:19 UTC
Keith R. AlexandraCEO - Beauty
GrantCommon Stock 2,509 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-008534 · form4.xml · nonDerivative · entry 2

Keith R. Alexandra · CIK 0001710268 · CEO - Beauty

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 10,984.381

F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan.

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:19 UTC
Keith R. AlexandraCEO - Beauty
GrantCommon Stock 11,255 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-008534 · form4.xml · nonDerivative · entry 1

Keith R. Alexandra · CIK 0001710268 · CEO - Beauty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,106.032

F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan.

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:26 UTC
Fish Kathleen BChf Rsch, Dev & Innv Officer
GrantStock Option (Right to Buy) · Derivative 85,510 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008545 · form4.xml · derivative · entry 3

Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,510

Underlying: Common Stock · 85,510 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:27 UTC
Francisco Ma. FatimaCEO - Baby & Feminine Care
GrantStock Option (Right to Buy) · Derivative 100,456 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008547 · form4.xml · derivative · entry 4

Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,456

Underlying: Common Stock · 100,456 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:28 UTC
Taylor David SDirector · Chairman, President & CEO
GrantStock Option (Right to Buy) · Derivative 226,898 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008548 · form4.xml · derivative · entry 3

Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,898

Underlying: Common Stock · 226,898 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:28 UTC
Taylor David SDirector · Chairman, President & CEO
GrantCommon Stock 30,359 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-008548 · form4.xml · nonDerivative · entry 1

Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 242,702.6064

F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan.

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:29 UTC
FergusonMchugh MaryLynnCEO - Family Care & P&G Ventur
GrantCommon Stock 14,785 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-008549 · form4.xml · nonDerivative · entry 1

FergusonMchugh MaryLynn · CIK 0001613133 · CEO - Family Care & P&G Ventur

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,499.7592

F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 14:24 UTC
Sheppard Valarie LController, Treas. & Exec. VP
GrantStock Option (Right to Buy) · Derivative 49,505 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008738 · form4.xml · derivative · entry 3

Sheppard Valarie L · CIK 0001334175 · Controller, Treas. & Exec. VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,505

Underlying: Common Stock · 49,505 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 3, 2020 14:26 UTC
Bishop Steven DCEO - Health Care
GrantStock Option (Right to Buy) · Derivative 82,876 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008739 · form4.xml · derivative · entry 5

Bishop Steven D · CIK 0001669212 · CEO - Health Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,876

Underlying: Common Stock · 82,876 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 3, 2020 14:26 UTC
Bishop Steven DCEO - Health Care
GrantCommon Stock 3,697 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-008739 · form4.xml · nonDerivative · entry 1

Bishop Steven D · CIK 0001669212 · CEO - Health Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,025.179

F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 14:27 UTC
Majoras Deborah PChief Legal Officer & Secy
GrantStock Option (Right to Buy) · Derivative 46,644 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008740 · form4.xml · derivative · entry 3

Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,644

Underlying: Common Stock · 46,644 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 3, 2020 14:27 UTC
Majoras Deborah PChief Legal Officer & Secy
GrantCommon Stock 6,241 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-008740 · form4.xml · nonDerivative · entry 1

Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,537.151

F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 14:29 UTC
Grabowski Mary TheresaChief Human Resources Officer
GrantStock Option (Right to Buy) · Derivative 66,921 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008741 · form4.xml · derivative · entry 5

Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,921

Underlying: Common Stock · 66,921 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 3, 2020 14:34 UTC
Pritchard Marc S.Chief Brand Officer
GrantStock Option (Right to Buy) · Derivative 87,161 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008744 · form4.xml · derivative · entry 8

Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,161

Underlying: Common Stock · 87,161 shares

Expires 2030-02-28

Read SEC document
February 28, 2020 Filed Mar 3, 2020 14:30 UTC
Coombe Gary ACEO - Grooming
GrantStock Option (Right to Buy) · Derivative 100,456 $0.00 Strike: $113.23 $0.00
Disclosure

SEC source: 0001127602-20-008742 · form4.xml · derivative · entry 5

Coombe Gary A · CIK 0001623622 · CEO - Grooming

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,456

Underlying: Common Stock · 100,456 shares

Expires 2030-02-28

Read SEC document
February 27, 2020 Filed Feb 28, 2020 13:46 UTC
Fish Kathleen BChf Rsch, Dev & Innv Officer
SaleCommon Stock 1,213 $117.49 $142,513.43
Disclosure

SEC source: 0001127602-20-008263 · form4.xml · nonDerivative · entry 1

Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,985.829

F1 · price: Weighted average price of the shares sold. The price range was $117.31 to $117.55. Full information regarding the number of shares sold at each separate price available upon request.

Read SEC document
February 27, 2020 Filed Feb 28, 2020 19:30 UTC
TASTAD CAROLYN MGroup Pres-Chief Sales Officer
SaleCommon Stock 5,297 $117.49 $622,336.05
Disclosure

SEC source: 0001127602-20-008304 · form4.xml · nonDerivative · entry 1

TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,062.352

F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award.

F2 · price: Weighted average price of the shares sold. The price range was $117.31 to $117.55. Full information regarding the number of shares sold at each separate price available upon request.

F3 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.